Front Immunol 15:1372303
In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how orforglipron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, and more
Production trajectories were then run for an additional microsecond under the same simulation conditions
Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration
The AITC concentrations used were 50 M, 100 M, 300 M and 500 M, based on our recent study on the effect of AITC on root growth inhibition 74